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Abstract
Our purpose was to  analyze  the placental  volume and fetal  weight  ratio  in  diabetic
pregnancies  during  mid-pregnancy.  Fifty-four  diabetic  pregnancies  (27  gestational
diabetes  mellitus  (GDM) and 27 diabetes  mellitus  (DM) type  I  with good glycemic
control)  and  three-hundred  and  sixteen  healthy  cases  were  analyzed  by  three-
dimensional sonographic volumetry of the placenta, while fetal weight was estimated by
two-dimensional  technique.  The  gestational  age-specific  estimated  fetal  weight  and
placental  volume-to-fetal  weight ratio was significantly higher in GDM pregnancies,
whereas  placental  volume in GDM was similar  compared to control  data.  DM with
good glycemic  control did not predispose to any changes in sonographic volumetric
differences compared to control values. The disproportional placental growth correlated
to fetal growth takes place in the second trimester in GDM, whereas DM with good
glycemic control does not pose a significant risk of unequal feto-placental development
in mid-pregnancy.
Keywords:  gestational diabetes mellitus, pregnancy; estimated fetal weight, placental
volume, three-dimensional ultrasound 
Abbreviations: DM type I: diabetes mellitus type I; EFW: estimated fetal weight; GA:
gestational age; GDM: gestational diabetes mellitus; PV: placental volume; s: second; 2
or 3-D: two or three dimensional 
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Introduction
The  placenta  has  a  limited  lifespan  which  significantly  determines  the  fetal
growth, since placental weight is strongly associated with the fetal and neonatal weight
(1-3). Placental volumetry is the most common way to characterize placental growth and
it is a summary of many dimensions of placental growth. Diabetic state has a profound
effect  on the microvasculature of developing placenta leading to increased volume of
terminal villi and to non-branching angiogenesis in type I diabetes (DM type I) (4-5) or to
degenerative lesions induced by chronic hypoxia in gestational diabetes mellitus (GDM)
(6) irrespective of the adequacy of glycemic control (5).
The prevalence of GDM and DM type I has increased over the past decade. DM
affects 0.5% of singleton pregnancies, whilst the prevalence of GDM is 1% (1) - 8.7%
(7). It is well established that a higher risk of large for gestational age infants and heavier
placentas are associated with maternal diabetes (1,8), but in a recent study was published
that placental weight-to-birth weight ratio is also higher among them (1). However, large
placentas related to birth weight is associated with more adverse perinatal outcome (1,2),
however  it  is  unclear  when  this  disproportional  ratio  appears  during  pregnancy
complicated by diabetes.
Therefore we aimed to describe the changes of placental growth and its relation to
fetal growth by gestational age (GA) in gestational diabetes, DM type I and in healthy
pregnant  women.  We  studied  both  types  of  diabetes  combined,  and  we  also  made
separate analyses for DM and GDM pregnancies in relation to gestational age.
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The control group consisted of 316 women and besides 54 pregnant women with
diabetes (27 had DM type I and 27 had GDM) were enrolled in the study and the studied
factors  were  as  follows:  estimated  fetal  weight  (EFW),  placental  volume  (PV)  and
placental  ratio  (PR)  as  defined  by  EFW/PV  (1).  Inclusion  and  exclusion  (e.g.
preeclampsia,  assisted  reproductive  technology)  criteria,  diagnostic  requirements  for
diabetes, determination of gestational age, fetal biometry and Doppler artery flowmetry
in uterine and umbilical arteries were described in our previous article (9). After standard
2-D measurements were taken, a 3-D sweep was performed through the placenta by a
Voluson 730 ultrasound machine (Voluson 730 system, RAB 2-5 MHz probe, and 4D
View version 10.4 program; GE Healthcare, Kretztechnik, Zipf, Austria) during a period
of maternal apnoea and fetal rest. The entire view of the placenta was identified by two-
dimensional ultrasound, and the volume box was adjusted to involve the entire placenta.
The angle of volume acquisition varied between 45º and 70º according to placental size.
The volume acquisition was obtained at ‘maximum’ speed and its duration was below 10
seconds keeping the probe perpendicular to the placental plate. A multiplanar technique
was applied and after the entire volume was scanned, the 3-D volumetric data were stored
on a removable hard disk. The longest view of the placenta on plane ‘A’ was chosen as
reference image. The same pre-established instrument settings were used in all the cases
(power 96%; frequency low; quality normal, density 6, ensemble 16; balance 150; filter
2; smooth 3/5; pulse repetition frequency 0.9 kHz). Each image was recovered from the
disk in succession for processing. The stored volumes were further analyzed using the
virtual  organ computer-aided  analysis  (VOCAL)  program pertaining  to  the  computer
software 4D VIEW (GE Medical  Systems,  Austria,  version 10.4) ,  which consists  of
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outlining the contour of the placenta repeatedly after rotating its image 6 times by 30°,
with careful attention to exclude decidua and maternal blood vessels. After the complete
rotation was finished, the placental volume was automatically calculated by the software.
For  each patient,  placental  volumes  were  measured  3 times  by a  specifically  trained
sonographer (A.S.) to eliminate inter-observer error.
Statistical  Package for  the Social  Sciences  was utilized  for Mann-Whitney U-
probes  and adjustments  were made  by multiple  logistic  regressions.  The associations
between PV, EFW and PR and 2-D color Doppler indices (pulsatility (PI) and resistance
indices  (RI)  of  umbilical  and  uterine  arteries)  were  determined  by  Spearman's  rank
correlations. The local medical ethics committee of University of Szeged approved the
study.
When the two diabetic groups were analyzed combined, the case and the control
group were satisfactorily comparable in relation to maternal  (range: 20-39 years)  and
gestational age (range: 10+0-28+2  weeks) as well as , whereas pregestational BMI (Table
1). Although all the studied sonographic parameters (EFW, PV and PR) were  similar
higher in the diabetes group, they and were not significantly different in the diabetes and
in the from the control group (p=0.904662, p=0.07681 and p=0.645154, respectively). If
the comparison of these modalities were adjusted for gestational age and BMI, it resulted
in  an  unchanged  pattern  (p=0.89902,  p=0.73421,  p=0.88930;  respectively).  Diabetes
subgroups  analyzed  separately  exhibited  the  following  results  concerning  GDM  vs.
control  group:  EFW:  40013±28966 vs.  28872±18593 grams,  p=0.274006;  PV:
253300±319  vs.  1889±1198cm3,  p=<0.046001 and  PR:  0.6396±0.2285 vs.
0.7586±0.4463 cm3/gram, p=0.29167) and regarding DM type I vs. control group: (EFW:
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27223±2174 vs.  288±185272±193 grams,  p=0.01211;  PV:  18755±99166 vs.
188±119cm3 189±118 cm3, p=0.667222 and PR: 0.856±0.2976 vs.  0.75±0.440.86±0.63
cm3/gram, p=0.034791). After adjustment for gestational age and BMI in the analyses, a
different  pattern  could  be  observed  in  GDM  DM  type  I  vs.  control  group  (EFW:
p=0.805017; PV: p=0.48175 and PR: p=0.39901) and in  GDM  DM type I  vs. control
group (EFW: p=0.825502; PV: p=0.798970 and PR: p=0.441701).
PVs and EFWs were plotted against gestational age, which showed exponential
trend lines (Figure 1), which are acceptable according to our previous study (10). The rise
of placental volume and fetal weight curves was the highest in DM type I, whereas trend
lines of GDM and control groups were below that of DM type I.
PR was significantly correlated only to the resistance index of the uterine artery
(p=0.007, r: 0.479) among 2-D color Doppler indices of the uteroplacental arteries.
Discussion
In  this  sonographic  study  of  singleton  pregnancies,  the  estimated  placental
volumes and fetal weights are higher in pregnancies with diabetes, but not significantly
different from the values of healthy control cases during mid-gestation. Thus a minimally
higher placental ratio is characteristic for diabetes between 10+0-28+2  weeks of gestation.
Since the placental and fetal weight is increasing exponentially by length of gestation
based on our present results, our data were adjusted for gestational age, and there was no
significant  difference  between  the  tendency  of  the  growth  of  placenta  and  fetus  in
maternal diabetes compared to the control cases during mid-pregnancy.
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Our data  may be consistent with the report  stating that  diabetic  mothers  have
larger placenta at birth, their offsprings’ weight and placental ratio are increased (1,6).
We suggest that the disproportional fetal growth correlated to placental development in
diabetes might occur generally in late pregnancy. 
Interestingly,  when  associations  were  checked  in  the  diabetic  subgroups,  the
infants in DM type I pregnancies were found to be larger and the corresponding placental
weight  was just  minimally-higher  than those in  the control  group, whereas the GDM
trend lines are similar to those of the control group. These results are also in line with the
results of  Stor-Røum et al. (1), who claimed that the DM type I pregnancies have the
largest placentas at birth, followed by pregnancies in GDM and normal population. These
facts  advocate  that  the  excessive  placental  growth is  already measurable  in  the  mid-
pregnancies  of  expectant  mothers  with  diabetes  type  I,  whereas  the  disproportionate
growth of the fetus and placenta might appear only in the late pregnancy in case of GDM.
This is indicated by the fact that the diabetic trend lines are increasing more precipitously
in the end of the studied period than trend lines of the control group. This is also in
accordance with the conclusions of our former study (10), that placental growth is more
significant in the latest phase of the gestation. In addition, our present study is also in
conformity with the only one study so far representing evidence on minimally increased
placental volumes  in utero in DM type I compared to pregnancies in the control group
(8), but this latter study was restricted to a gestational age between 11+0 and 13+6 weeks.
The placental volume does not correspond notably to uteroplacental flow, which is also
demonstrated earlier in normal pregnancies (11) and even in diabetic pregnancies (9). It is
noteworthy,  that  our  sample  is  collected  based  on  the  new  principles  of  criteria  of
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diabetes, whereas there has not been reported any reports on placenta ratio according to
the new guidelines.
Although a relative small number of participants were investigated in the present
study, the prevalence of diabetes is low in the pregnant population (particularly diabetes
type I) and this may allow to draw definitive conclusions. Our results demonstrate that it
would be useful to improve our understanding on the pathophysiological constraints in
diabetes in early and mid-pregnancy. Patient with diabetes type I were involved in our
study, because in this case the sensitivity and specificity is high (the validity of diabetes
type II may be uncertain which can cause possible misclassification) (1). A well-known
technical  limitation  of  placental  volumetry  is  that  a  minority  of  placentas  can  be
visualised entirely at late gestation, so we could not estimate placental volumes in the
third trimester (10).
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Table 1. Demographic and ultrasound characteristics of the study groups. Data are presented as
mean±standard deviation.
Diabetic group (N=54) Control group
(N=31924)
p value
Maternal age (years) 312.741±3.951 31.3593±63.9187 0.514891
Maternal  pregestational  BMI
(kg/m2)
278.439±6.782.40 217.7591±1.842.32 0.0010.761
Gestational  age  at  the  time  of
ultrasound examination (weeks)
19.38±4.31 18.43±3.813 0.375099
Estimated fetal weight (grams)* 35018.2845±26882.6319 2871.6976±18593.0846 0.904662
Placental volume (cm3)** 227.38±152.03 188.2266±118.5430 0.07681
Placental ratio (cm3/g)*** 0.79183±0.272534 0.753857±0.444627 0.645154
* Estimated fetal weight based on Hadlock ‘B’ formula (Hadlock)
** measured with the help of 4D View program (VOCAL technique)
*** Placental ratio: placental volume relative to the estimated fetal weight
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Figure 1. Sonographic characteristics in the study  groups
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